HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

MHC class II transactivator protein

a major histocompatibility complex class II transactivator; essential for transcriptional activity of the HLA class II promoter; activation is via the proximal promoter; defects in MHC2TA are a cause of BARE LYMPHOCYTE SYNDROME type II (BLS II), a severe form of SCID; RefSeq NM_000246 (human); NM_007575 (mouse)
Also Known As:
C2TA protein, human; C2ta protein, mouse; CIITA protein, human; CIITA protein, mouse; MHC class II transactivator protein, human; MHC2TA protein, human; Mhc2ta protein, rat; class II transactivator; class II transactivator protein, mouse
Networked: 122 relevant articles (2 outcomes, 8 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Accolla, Roberto S: 5 articles (10/2014 - 05/2003)
2. Swanberg, Maria: 4 articles (01/2021 - 05/2005)
3. Gascoyne, Randy D: 4 articles (11/2015 - 11/2009)
4. Rimsza, Lisa M: 3 articles (11/2015 - 11/2009)
5. Steidl, Christian: 3 articles (11/2015 - 03/2011)
6. De Lerma Barbaro, Andrea: 3 articles (09/2010 - 06/2006)
7. Mortara, Lorenzo: 3 articles (09/2010 - 06/2006)
8. Lidman, Olle: 3 articles (07/2009 - 05/2005)
9. Olsson, Tomas: 3 articles (07/2009 - 05/2005)
10. Piehl, Fredrik: 3 articles (07/2009 - 05/2005)

Related Diseases

1. Neuroinflammatory Diseases
2. Glioblastoma (Glioblastoma Multiforme)
3. Neoplasms (Cancer)
4. Melanoma (Melanoma, Malignant)
5. Lymphoma (Lymphomas)

Related Drugs and Biologics

1. Histocompatibility Antigens Class II
2. Proteins (Proteins, Gene)
3. Phosphotransferases (Kinase)
4. Interferon-gamma (Interferon, gamma)
5. HLA-DR Antigens (HLA-DR)
6. Transcription Factors (Transcription Factor)
7. Messenger RNA (mRNA)
8. Peptides (Polypeptides)
9. Regulatory Factor X1
10. CTLA-4 Antigen

Related Therapies and Procedures

1. Biological Therapy
2. Immunotherapy